Shareholder Alert: The Ademi Firm investigates whether Evoke Pharma Inc. is obtaining a Fair Price for its Public Shareholders
Provided By PR Newswire
Last update: Nov 4, 2025
MILWAUKEE, Nov. 4, 2025 /PRNewswire/ -- The Ademi Firm is investigating Evoke (NASDAQ: EVOK) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction.
Read more at prnewswire.comNASDAQ:EVOK (11/13/2025, 2:31:02 PM)
10.69
+0.01 (+0.09%)
Find more stocks in the Stock Screener
EVOK Latest News and Analysis
7 days ago - By: Chartmill
